Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD

February 10, 2026 updated by: Lauren Kenworthy, Children's National Research Institute
This project explores the association between learning and cognitive flexibility by testing whether a cognitive behavioral intervention designed to improve flexibility in ASD changes learning and associated neural activation using model-based functional magnetic resonance imaging (m-fMRI). The study proposes that variability in learning mechanisms is associated with behavioral flexibility and explains differences in adaptive and treatment outcomes. The study employs a longitudinal case-controlled design in 60 14-18 year old youth with ASD at 3 time-points 8 months apart, each including m-fMRI during learning and behavioral measurement of executive and adaptive function. Aim 1 tests the hypothesis that individual variation in learning biases and their neural correlates predicts behavioral flexibility and is stable over time. Aim 2 tests plasticity of learning mechanisms induced by a cognitive-behavioral intervention for flexibility. Aim 3 tests hypothesis about intervention-induced plasticity of neural functional connectivity.

Study Overview

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • District of Columbia
      • Washington D.C., District of Columbia, United States, 20010
        • Children's National Hospital
      • Washington D.C., District of Columbia, United States, 20057
        • Georgetown University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 14-18 years of age inclusive
  2. Full scale IQ > 80 on a standardized IQ test, either confirmed through educational testing within the last two years or confirmed by the Wechsler Abbreviated Scale of Intelligence (WASI-2) administered by research personnel. If current IQ testing (FSIQ) is not interpretable based on discrepancies between verbal and perceptual skills, we will use the best available verbal IQ estimate.
  3. Broad ASD diagnosis according to Diagnostic Statistical Manual, fifth edition (DSM-5) criteria established by parent report of prior clinical diagnosis and confirmed by meeting cutoff criteria on the Social Communication Questionnaire (i.e., raw score > 11) or the Autism Diagnostic Observation Schedule-2 (ADOS-2), Module 4 (total score ≥7).
  4. Intact or corrected hearing and vision.
  5. Parents/guardians speak and read English with sufficient fluency for completion of consent forms and informant questionnaires; youth participants will use/understand English as a primary or secondary language with sufficient fluency to engage effectively in executive function group therapy conducted in English, and for valid administration of neuropsychological and behavioral measures.

Exclusion Criteria:

  1. Presence of a known medical condition in the participant that would interfere with his/her ability to participate in the study.
  2. To preserve the integrity of the neuroimaging data, participants will be excluded if they have a history of neurological disorder, such as an established epilepsy diagnosis, significant brain trauma, hydrocephalus, central nervous system infection, or stroke.
  3. Contraindications for MRI such as metal implants, dental braces, pregnancy (determined by parent or self-report).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Executive function group therapy
This executive function group therapy curriculum for adolescents uses cognitive behavioral therapy techniques, and focuses on key functions needed for adult success, such as: self-advocacy, flexibility, time management, motivation, goal setting, developing plans, monitoring progress. Guided practice begins with concrete interventionist support and moves to interventionist cueing, self-cueing, and finally automatic use of the skills without support.
Other Names:
  • Proprietary name: Unstuck & On Target (UOT:HS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Executive Function Challenge Task (EFCT) Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
The EFCT is an objective and ecologically valid task developed by our research team to assess flexibility and planning skills in a social context conducted by a trained research staff member masked to treatment condition. The EFCT uses a standardized, semi-structured protocol which does not provide explicit rules for completing the tasks to mimic the implicit, unspoken, unstructured expectations in everyday life. The EFCT consists of challenges across several activities and responses are scored on a 3-point scale for each task. The scale (0-good, 1-intermediate, 2-poor performance) has task-specific behavioral markers to guide scoring.
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in Neural Response During Prototype Learning Task Outcomes
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
The Prototype Task measures learning of abstract representations in the visual domain. The task requires classification into two categories of visual exemplars characterized by a number of features (e.g., cartoon fish with features such as a particular eye shape, fins, body shape etc.) for training with feedback. Following training, generalization of learned information is tested on exemplars that are similar to training items but have never been presented before. Participants perform the generalization phase in an MRI scanner for measurement of brain activation. Learning of abstract visual representation (e.g., prototype learning) on this task is indicated by engagement of medial prefrontal cortex (mPFC)
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Adaptive Behavior Assessment System, Third Edition (ABAS-3) scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Adaptive behavior will be measured via parent-report on the Adaptive Behavior Assessment System, Third Edition (ABAS-3). The ABAS-3 is a well-validated parent report measure that assesses practical, everyday skills needed to effectively and independently take care of oneself and interact with others across the lifespan.
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Prototype Task Performance: Learning Strategy Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Generalization phase learning can be characterized by strategy using computational modeling. Two models are tested; 1. learning from having abstracted information that is prototypical of the category (e.g., family of fish as described above); 2. Learning from matching exemplar information to training phase
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
The BRIEF-2 is a well-established self-report measure of real-world EF skills, with the Shift subscale measuring cognitive flexibility.
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Change in Dimensional Change Card Sort Test (DCCS) Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
The Dimensional Change Card Sort Test (NIH Toolbox) is a 4-minute, standard lab-based task for assessing cognitive flexibility in terms of set-shifting. Participants are required to sort a series of bivalent cards first according to one dimension (e.g., color) and then according to another (e.g., shape). It is normed from ages 4-85
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in Flexibility Scale Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
The Flexibility Scale (FS) is a 27-item measure assessing five categories related to flexibility: routines and rituals, transitions/change, special interests, social flexibility and generativity
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Change in CVLT-C Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
California Verbal Learning Test Children's Version (CVLT-C) is used to assess verbal learning and memory through an everyday memory task in which the child is asked to recall a list. The measure is for children and adolescents 5 through 16.11 years
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in CVLT-3 Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
California Verbal Learning Test Adolescent and Adult Version (CVLT-3) is used to assess verbal learning and memory through an everyday memory task in which the individual is asked to recall a list. The measure is for Individuals between 16-90 years old
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in ASC - ASD Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
The Anxiety Scale for Children- ASD (ASC-ASD) is a 24 item self-report anxiety questionnaire, with four sub-scales: Separation Anxiety (SA), Uncertainty (U), Performance Anxiety (PA) and Anxious Arousal (AA), for use with young people aged between 8-16 years with a diagnosis of autism spectrum disorder (ASD).
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Change in AIR-SDS Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
The AIR Self-Determination scale (AIR-SDS) produces a profile of the student's level of self-determination, identifies areas of strength and areas needing improvement, identifies specific educational goals that can be incorporated into the student's individualized education plan (IEP). The measure examines two broad self-determination components. Capacity refers to the student's knowledge, abilities, and perceptions that enable them to be self-determined. Opportunity refers to the student's chances to use their knowledge and abilities
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Change in PRAS-ASD Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Parent-Rated Anxiety Scale for Autism Spectrum Disorder (PRAS-ASD) is 25-item measure for anxiety. This is a reliable and valid measure that can be used to assess severity of anxiety in youth with ASD and evaluate change with treatment
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Change in Rey Complex Figure Test and Recognition Trial Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Rey Complex Figure Test and Recognition Trial (RCFT) tests visuospatial constructional ability and visuospatial memory using the "complex figure." The RCFT consists of four separate tasks and is scored using specific criteria developed for scoring the accuracy and placement of individual units of the complex figure
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
Change in BDI-II Scores
Time Frame: 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression
8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2021

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Study Registration Dates

First Submitted

September 30, 2021

First Submitted That Met QC Criteria

November 12, 2021

First Posted (Actual)

November 23, 2021

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Executive function group therapy

Subscribe